VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1812326
Sex: M
Age:
State: MO

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Dose 1: Legs became week. Could move them, but not stand up on them. Lasted approximately 2-3 hours. Reaction occurred within 15 minutes after the shot. Nurses made me go to the ER.; Dose 1: Legs became week. Could move them, but not stand up on them. Lasted approximately 2-3 hours. Reaction occurred within 15 minutes after the shot. Nurses made me go to the ER.; This is a spontaneous report from a contactable consumer (Patient himself). A 57-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ER8727 and expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 26Mar2021 12:15 as dose 1, single for COVID-19 immunization (Age at Vaccination was 57 years). The patient also received (other vaccine 4 weeks prior COVID vaccine) Diphtheria vaccine toxoid, Pertussis vaccine acellular 5-component, Tetanus vaccine toxoid (ADACEL, Lot Number: C5667AA), via an unspecified route of administration, administered in Arm Left on 11Mar2021 as dose 1, single for an unspecified indication and PMC (Sanofi). The patient medical history included Epilepsy, Migraine, Central Vestibular Disorder, and allergic to Sulpha Drugs and Shellfish from an unknown date and unknown if ongoing. Concomitant medications (Other medications in two weeks) included Clonazepam, Lacosamide, Lamotrigine and Omeprazole. It was reported that, he was not diagnosed with COVID prior vaccination and not tested with COVID post vaccination. On 26Mar2021 12:30, the patient experienced that his Legs became week, could move them, but not stand up on them, lasted approximately 2-3 hours, reaction occurred within 15 minutes after the shot. Nurses made him go to the ER. The patient has visited Emergency room as a result of events. The information regarding therapeutic measures taken as a result of events was unknown. The outcome of the events was recovered with sequelae on unspecified date of 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: CLONAZEPAM; LACOSAMIDE; LAMOTRIGINE; OMEPRAZOLE

Current Illness:

ID: 1812327
Sex: F
Age:
State: NM

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Muscle pain; Joint pain; Feeling cold; Headache; Tired; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the right arm on 27Apr2021 at 12:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 06Apr2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 01:45, the patient experienced muscle pain, joint pain, felt cold, headache and tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle pain, joint pain, felt cold, headache, tired was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812328
Sex: F
Age:
State: NY

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Hives on flank; heavier on opposite side from injection site; Rash on vaccine side of body under where purse strap rested/placed pressure; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 03May2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The medical history included nickel allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included escitalopram oxalate (LEXAPRO), desogestrel/ ethinylestradiol (MIRCETTE) and women's gummy multivitamin, all from unknown dates for unknown indications and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN), linalool (MANUFACTURER UNKNOWN) and experienced allergy. On 04May2021, the patient experienced hives on flank, heavier on opposite side from injection site and rash on vaccine side of body under where purse strap rested/placed pressure. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hives on flank and rash on vaccine side of body under where purse strap rested/placed pressure were resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEXAPRO; MIRCETTE

Current Illness:

ID: 1812329
Sex: F
Age:
State: MI

Vax Date: 04/20/2021
Onset Date: 05/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Developed a rash; it looks like hives; Developed a rash; it looks like hives; This is a spontaneous report from a contactable consumer (patient's parent). A 16-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EW0162, Expiry date: not reported) (age at the time of vaccination was 61 years), administered in Arm Left on 20Aper2021 as dose 2, single for COVID-19 immunization. The patient's medical history included pre-diabetic. The patient's concomitant medication was not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: not reported), via an unspecified route of administration, on 01Apr2021 as dose 1, single for COVID-19 immunization. On 03May2021, the patient developed rash it looks like a hives. Treatment received included benadryl. The outcome of the events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1812330
Sex: F
Age:
State: OR

Vax Date:
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Home Pregnancy test; Test Result: Negative ; Comments: taken 3 at home pregnancy tests and all are negative; Test Date: 20210420; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Menstrual period was supposed to start on April 17, it is now May 5 and still not started; This is a spontaneous report from a contactable nurse, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E19262) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) taken for an unspecified indication from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK9231) via an unspecified route of administration in the left arm on 22Jan2021 at 13:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021, the patient's menstrual period was supposed to have started and until 05May2021, it had still not started. Her cycle was generally very normal and she had taken 3 home pregnancy tests and all were negative. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 20Apr2021, the patient underwent SARS-COV-2 test via nasal swab and the result was negative. The clinical outcome of the event menstrual period was supposed to have started and until 05May2021, it had still not started was unknown at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: BUPROPION

Current Illness:

ID: 1812331
Sex: F
Age:
State: CA

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fever; Muscle aches; Joint aches; Brain fog; Anxiety; Headache; Increased tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0173) via an unspecified route of administration in the left arm on 04Apr2021 at 11:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis and allergy to wheat. Concomitant medications included ferrous gluconate, vitamins nos, herbal nos (FLORADIX) taken for iron supplementation from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021 at 12:00, the patient experienced fever, muscle aches, joint aches, brain fog, anxiety, headache and increased tinnitus. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, muscle aches, joint aches, brain fog, anxiety, headache and increased tinnitus was resolved on an unknown date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 02May2021 at 11:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: FLORADIX

Current Illness:

ID: 1812332
Sex: M
Age:
State: OH

Vax Date: 05/02/2021
Onset Date: 05/02/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Insomnia; Dose 1: 17Apr2021 and Dose 2: 02May2021; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 02May2021 at 12:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 12:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 16:00, the patient experienced insomnia. The event insomnia did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event insomnia was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812333
Sex: F
Age:
State: MO

Vax Date: 04/15/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Foot and ankle pain with swelling; Foot and ankle pain with swelling; Foot and ankle pain with swelling; Foot and ankle pain with swelling; Severe fatigue; Plantar fasciatis had become inflammed; Body aches; Energy level is low; Brain felt a little foggy; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 15Apr2021 at 08:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertensive, flat feet, obesity and COVID-19 in Jan2021. The patient had no known allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's concomitant medications included driven nutrition HERS multivitamin for an unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 25Mar2021 at 08:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 10:00(day 3), the patient experienced body ache. On 18Apr2021, the patient's plantar fasciatis had become inflammed (usually pain was managed and stayed around a level 2 on a scale from 1-10 prior to shot) and experienced severe fatigue. On 20Apr2021 (day 6), the patient's plantar fasciatis pain level had been around level 7-9 with no new activity to create the extra pain. On an unknown date in Apr2021 (second week after vaccination), the patient's energy level was not too bad and as long as the patient stretched a lot and took some ibuprophen (MANUFACTURER UNKNOWN), the patient was ok. On 30Apr2021 (day 16), the patient had lots of fatigue, along with foot and ankle pain with swelling. Generally, the patient's legs felt swollen, energy level was low, a few days the patient's pain level had been high in her foot/ankle, along with general body aches. Even with 6 pills of ibuprophen (MANUFACTURER UNKNOWN) (200mg each) in one day, it just kept the pain/aches to a dull level. On an unknown date in 2021, the patient's brain felt a little foggy. The patient had an appointment with her podiatrist to examine her foot and ankle. At the time of this report, the patient was 21 days post her second dose of the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events brain felt a little foggy, energy level is low, body aches, severe fatigue, plantar fasciatis had become inflamed, foot and ankle pain with swelling was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812334
Sex: F
Age:
State:

Vax Date: 04/22/2021
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Heart rate; Result Unstructured Data: Test Result:resting heart rate over 100

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Fever; poor circulation in hands and feet; resting heart rate over 100; severe abdominal cramps; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant adult female patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW150) via an unspecified route of administration in the arm left on 22Apr2021 at 18:00, as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. On an unknown date in 2021, the patient experienced fever, poor circulation in hands and feet, resting heart rate over 100 and severe abdominal cramps. On an unknown date in 2021, the patient's heart rate was measured and the result was found to be resting heart rate above 100. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, poor circulation in hands and feet, resting heart rate over 100 and severe abdominal cramps were resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812335
Sex: F
Age:
State: NC

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Sore R armpit; swollen lymph nodes in armpit and throat; swollen lymph nodes in armpit and throat; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 04May2021 at 10:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8729) via an unspecified route of administration in the right arm on 13Apr2021 at 10:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. On 05May2021 at 10:00, the patient experienced sore right armpit and swollen lymph nodes in armpit and throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore right armpit and swollen lymph nodes in armpit and throat was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812336
Sex: F
Age:
State: GA

Vax Date: 03/31/2021
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: I had two COVID tests; Result Unstructured Data: Test Result:unknown; Test Date: 202103; Test Name: I had two COVID tests; Test Result: Negative

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: I am not feeling well/ I was already not feeling very well when I got the first vaccination; I received the first one, I was feeling little lousy; Felt like type of little weird; I was tired after that the usual pain that was sore arm; I was tired after that the usual pain that was sore arm; This is a spontaneous report from a contactable consumer (Patient). A 48-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8733, Expiry date was not reported), via an unspecified route of administration on 31Mar2021 (at the age of 48-years-old) in Arm Left as single dose for COVID-19 immunization. Patient received tetracycline hydrochloride (TETRACYCLIN), route of administration, start and stop date, batch/lot number and dose were not reported for urinary tract infection. The Patient Medical history included type 1 diabetes mellitus, gastrooesophageal reflux disease, attention deficit hyperactivity disorder, cardiac disorder, ongoing urinary tract infection. Concomitant medications included insulin taken for an unspecified indication, start and stop date were not reported; furosemide taken for an unspecified indication, start and stop date were not reported; amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported; pantoprazole sodium sesquihydrate (PROTONIX) taken for an unspecified indication, start and stop date were not reported. The patient received other products. Consumer stated, she was calling because, On unspecified date she was not feeling well and she have some underlying issues (history). She just got the second COVID vaccination shot last Wednesday and she do have underlying issues like she was a diabetic and also a heart patient (clarified as history). She was on antibiotic for UTI infection when she received the first vaccination, so she was on Tetracycline at that time and she do think, she still have the UTI infection going on. So, she was already not feeling very well when she got the first vaccination but then she felt better, she was feeling better and she was told to go ahead for the vaccination. When she received the first one, she was feeling little lousy like she don't know maybe an hour later just felt like type of little weird but it was not a big deal but may be it was from the vaccination. So, she just went home and felt better and she was tired after that the usual pain that was sore arm and all that but it was not a big deal. Consumer further stated, The same thing had happened immediately with the first one and she was there for quite a while and she went to shopping at (Withheld) so it was probably like an hour and half but before she felt that weird, crazy and lightheaded feeling that wasn't until hours or two hours later. Consumer further stated, So she do want to report it because it helping more people to do share what is going through otherwise how will we know. She was keen to report it but she didn't do anything until this time and then she was waiting for the things to go away before she reported anything that is how is going on. Event start date: Consumer stated, All these started right after the shot actually like the lousiness and fatigue that started after the shot and it got little bit better after first shot and it came back after the second shot and increased immensely. Actually, the lousiness stated after couple of hours later but the rest of the symptoms started the next day or the day after like couple of days later. So, after the first shot on 04/02, I started the side effects and they were like worse after couple of days later and with the second one it was like the same thing. (not clarified further). Consumer stated, she have a heart condition and she believe she was 16 years old when she was diagnosed with Type 1 diabetes and she take two types of insulin. Consumer stated, she had two COVID tests and she took one in March and they tried to give me one for my UTI infection but they couldn't get any blood because she was dehydrated, she was always dehydrated. (not clarified further). Still experiencing event consumer stated, Yes they are much worse. (event not appropriately paraphrased and clarified further, hence ongoing not checked for events). Treatment: Consumer stated, "No, she haven't done anything yet because she was expecting it go away and instead it is getting worse. She didn't had that much after the first one but from the second on everyday it is getting worse. The patient underwent lab tests and procedures which included sars-cov-2 test: unknown on, sars-cov-2 test: negative on Mar2021. The outcome for the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: INSULIN; FUROSEMIDE; ADDERALL; PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]

Current Illness: Urinary tract infection

ID: 1812337
Sex: F
Age:
State: CA

Vax Date: 04/26/2021
Onset Date: 05/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: On the 7th day a red rash also appeared on legs; Tenderness, redness and swelling on both breasts; Tenderness, redness and swelling on both breasts; Tenderness, redness and swelling on both breasts; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 26Apr2021 at 14:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included ductal carcinoma in situ (DCIS) in 2011 and recent urinary tract infection (UTI); both were unknown if ongoing and it was reported that she had implants due to breast reconstruction in 2011 following a bi-lateral mastectomy. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified antibiotics for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 04Apr2021 at 12:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 15:00, 5 days after the second dose, the patient experienced tenderness, redness and swelling on both breasts. On 03May2021, 7 day after the vaccination, the patient had red rash appeared on her legs. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with unspecified antibiotics where her doctor feared for possible infection. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tenderness, redness and swelling on both breasts and red rash appeared on her legs was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812338
Sex: M
Age:
State: MD

Vax Date: 05/03/2021
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: body ache; fever; headaches; chills; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 64-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in arm left on 03May2021 14:00 (at the age of 64 years old) as dose 2, single for COVID-19 immunization. Medical history included covid-19 from Feb2021 to an unknown date "mild and recovered in a week and Food allergy. The patient concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in upper arm left hand side on 07Apr2021 8:30 (at the age of 64 years old) as dose 1, single for COVID-19 immunization and experienced pain in the hip, skin reaction and reports difficulty walking like he had arthritis that attacked his joints and knees and he used to have this from gluten products and so instead of taking glucocorticoids or steroids, he took Melatonin and his symptoms went away after 1-2 days after taking the Melatonin. Transferring agent states the caller reported from the 2nd dose of the Pfizer COVID Vaccine he had body aches, headache, chills and fever and stated he had covid in February with mild symptoms and he recovered from covid in one week; states the caller also read that people that had covid have like 140 times the protection and it elevates the immune system 140 times. Caller verified the information provided by the transferring agent and states he had no side effects for one week after the 1st dose of the Pfizer COVID Vaccine and after that his body was slanted 40 degrees and he had to take his weight to the backside of his body to balance and had pain in his hip. States the Melatonin he took was 3mg and is a neurotransmitter like serotonin and is the Simple Truth brand and has expiry date May2023. Caller states after the 2nd dose of the Pfizer COVID Vaccine, the chills and fever began 6-7 hours after the dose was administered and he had a headache and had body chills and a slight fever and was shivering with chills and under a double blanket with it 80 degrees outside. Reporter details: Caller states he was not a HCP but reads all the stuff and this is a special interest of his and he is an engineer. States he did not have any side effects after the 1st dose of the Pfizer Covid Vaccine for one week after that week then his body was slanted 45 degrees; states he cured himself and required no further treatment using the Melatonin and has some kind of memory of reading where some HCPs in another country administered Melatonin to moderate immune symptoms or people with immune systems and it attached to the lung cells; states some HCPs experiment with Melatonin and it worked in some patients; states he has no patient information or lot numbers of their vaccines or for Melatonin to provide. states both doses were administered to the upper arm of the left hand side and the 1st dose of the Pfizer COVID Vaccine was a scratch mark and a skin reaction so the 2nd dose was put a little up above that for the 2nd dose. Caller states he wanted to report this information and it was good and worked for him and maybe it would work for some people that experience the same difficulty with bone slanting or if the have a gluten sensitivity or autoimmune or something like that and he wanted to forward it to be useful to this group. On an unspecified date patient experienced body ache, fever, headaches and chills. The patient didn't received, any vaccine prior Vaccinations. Patient didn't received, any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the events was unknown. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1812339
Sex: F
Age:
State: IA

Vax Date: 04/16/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: My sense of smell and taste have been altered.; My sense of smell and taste have been altered.; I cannot eat without having a burnt taste in my mouth.; Many things I cannot smell; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 12:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Apr2021, the patient experienced sense of smell and taste had been altered and the patient could no longer enjoy any fried food, most meat, and a lot of grilled style foods, she couldn't eat without having a burnt taste in her mouth and many things she couldn't smell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sense of smell and taste had been altered, burnt taste in mouth and many things she couldn't smell was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1812340
Sex: F
Age:
State: OH

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Fever; Chills; Body aches; Headache; Upset stomach; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04May2021 at 09:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 18:30, the patient experienced fever, chills, body aches, headache and upset stomach. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, chills, body aches, headache and upset stomach were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1812341
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Restlessness; Insomnia; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. It was not reported if the patient had received other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced restlessness and insomnia. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events restlessness and insomnia were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1812342
Sex: F
Age:
State: CA

Vax Date: 04/09/2021
Onset Date: 04/15/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Itching of entire body; Profuse sweating at night; Insomnia; This is a spontaneous report from a contactable other healthcare professional, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 01:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included hypersensitivity reactions and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications within 2 weeks prior to the vaccination. On 15Apr2021, the patient experienced itching of entire body, profuse sweating at night and insomnia for 2 weeks. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event insomnia was resolved with sequelae on 29Apr2021, after the duration of two weeks while that of the events itching of entire body and profuse sweating at night were resolved with sequelae on an unknown date in 2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1812343
Sex: M
Age:
State: AZ

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Headache; Pain at the injection location; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 at 19:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient has no known allergies. Concomitant medications included venlafaxine (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and empagliflozin (JARDIANCE) all taken for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 20:00, the patient experienced headache for about 5 hours and slight headache 15 hours later, improving and pain at the injection location. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and pain at injection location was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VENLAFAXINE; SIMVASTATIN; METFORMIN; LISINOPRIL; JARDIANCE

Current Illness:

ID: 1812344
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: Fertility hormonal test; Result Unstructured Data: Test Result:Low fertility hormones

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Extended menstrual period (more than 10days); Low fertility hormones; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration on an unknown date (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unknown date, the patient experienced extended menstrual period (more than 10 days) and low fertility hormones. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient underwent lab tests and procedures included fertility hormonal test and the result was found to be low fertility hormones. The clinical outcome of the events extended menstrual period (more than 10 days) and low fertility hormones was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812345
Sex: F
Age:
State:

Vax Date: 03/13/2021
Onset Date: 04/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Fever; Chills; Headache; Sever Body aches; Change in menstrual cycle up to and possible beyond 2 month of last dose; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 13Mar2021 at the age of 39-years-old as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, atopic dermatitis, asthma, calculus of the kidney, migraines, cystic-bullous disease of lung, and multiple idiopathic pulmonary cysts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medication within two weeks of vaccination. The patient previously received ESTROGEN from an unknown date for an unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 20Feb2021 at the age of 39-years-old as a single dose for COVID-19 immunisation. On 12Apr2021, the patient experienced fever, chills, headache, sever body aches, changes in menstrual cycle up to, and possible beyond 2 months of last dose. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, headache, sever body aches, change in menstrual cycle up, and possible beyond 2 months of last dose was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812346
Sex: M
Age:
State:

Vax Date: 04/27/2021
Onset Date: 04/30/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: About three days after injection, it felt like a cut had opened at the injection site and then a thin vertical scab about 0.5 inches long formed at the injection site. The scab is still there 2 weeks; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 27Apr2021 at 10:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Apr2021, about three days after injection, the patient felt like a cut had opened at the injection site and then a thin vertical scab about 0.5 inches long formed at the injection site. The scab was still there 2 weeks later. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt like a cut had opened at the injection site and then a thin vertical scab about 0.5 inches long formed at the injection site was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812347
Sex: M
Age:
State: PA

Vax Date: 04/27/2021
Onset Date: 05/02/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Severe pain in right arm; Severe pain in shoulder; This is a spontaneous report from a non-contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the arm left on 27Apr2021 at 17:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 06Apr2021 20:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 02May2021, after moderate yard work during afternoon, at 23:00 the patient experienced severe pain in right arm and severe pain in shoulder. The patient reported that, the pain was worsening. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with unspecified pain killer and ice pad. The clinical outcome of the events severe pain in right arm and severe pain in shoulder was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812348
Sex: F
Age:
State:

Vax Date: 04/28/2021
Onset Date: 05/02/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: I feel like I am in menopause again; difficulty getting back to sleep; hot flashes; night sweats; wake up during the night; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 12:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to sulfa and latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included aciclovir (ACYCLOVIR), magnesium glycinate (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D) and multi (MANUFACTURER UNKNOWN);all from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Apr2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 18:30 the patient reported that she feels like she was in menopause again. she woke up during the night or early in the morning and had difficulty getting back to sleep, she was also having hot flashes and night sweats. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events she feels like she was in menopause again, she woke up during the night or early in the morning and had difficulty getting back to sleep, she was also having hot flashes and night sweat were not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ACYCLOVIR [ACICLOVIR]; MAGNESIUM GLYCINATE; VITAMIN C [ASCORBIC ACID]; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1812349
Sex: F
Age:
State:

Vax Date: 04/19/2021
Onset Date: 05/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Very heavy and unusually early menstrual cycle (by 5 days); Very heavy and unusually early menstrual cycle (by 5 days); Also shorter in duration ( only 3 days instead of 5); It also is much thinner blood than usual; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration on 19Apr2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 01May2021, the patient experienced very heavy and unusually early menstrual cycle (by 5 days) and also shorter in duration (only 3 days instead of 5). It also was much thinner blood than usual. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very heavy and unusually early menstrual cycle (by 5 days), also shorter in duration (only 3 days instead of 5) and it also was much thinner blood than usual was recovered on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812350
Sex: F
Age:
State: MI

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Chills; High fever; Body aches; Splitting headache; Nausea; Sinus drainage; Earache; Stomach ache; This is a spontaneous report from a non-contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 15:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, a stroke in 2019 and allergy to penicillin and some antibiotics. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), hydrochlorothiazide (HYDRODIURIL) and acetylsalicylic acid (ASPIRIN), all taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 03:30, the patient experienced chills, high fever, body aches, splitting headache, nausea, sinus drainage, ear ache and stomach ache. On an unknown date in May2021, at day 10, the patient still had stomach ache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, high fever, body aches, splitting headache, nausea, sinus drainage and ear ache was resolving while stomach ache was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LISINOPRIL; HYDRODIURIL; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1812351
Sex: F
Age:
State: ID

Vax Date: 05/03/2021
Onset Date: 05/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Brain fog 24 hours after vaccination; waves of nausea; Very tired 20 hours after vaccination; Unable to keep eyes open 20 hours after vaccination; Very confused upon waking up 18 hours after vaccination. Extreme confusion 24 hours after vaccination; Very sore arm 4 hours after vaccination, lasted all second day; Very sore arm with burning sensation 4 hours after vaccination, lasted all second day; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 03May2021 at 12:00 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac, hypothyroidism, attention deficit hyperactivity disorder (ADHD), depression, obsessive-compulsive disorder (OCD), anxiety and allergy to strawberries. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol; etynodiol diacetate (KELNOR) from an unknown date indicated for birth control, lisdexamfetamine mesilate (VYVANSE) and levothyroxine (MANUFACTURER UNKNOWN), both from unknown date for unknown indication. On 03May2021 at 16:00, 4 hours after vaccination, the patient experienced very sore arm with burning sensation, lasted all second day. On 04May2021 at 08:00, 18 hours after vaccination, the patient was very confused upon waking up. On 04May2021 at 10:00, 20 hours after vaccination, the patient was very tired, unable to keep eyes open. On 04May2021 at 14:00, 24 hours after vaccination, the patient experienced, brain fog, extreme confusion and waves of nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore arm with burning sensation, very confused upon waking up, very tired, unable to keep eyes open, brain fog, extreme confusion and waves of nausea was not resolved at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds: KELNOR; VYVANSE; LEVOTHYROXINE

Current Illness:

ID: 1812352
Sex: F
Age:
State: CA

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210504; Test Name: Body temperature; Result Unstructured Data: Test Result:100.3; Comments: Slight fever

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Dizziness; Ringing in the ears; Headache; Nausea; Slight fever (100.3); Wheezing; Excessive fatigue; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 03May2021 at 09:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, high blood pressure (HBP),hypothyroidism, migraine, lymphedema, chronic pain, artificial joints- total knee replacement (TKR) both knees, both hands/thumbs; spinal fusion/plates/screws/bone at C5 &C7, hysterectomy and known allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications for HBP, migraines, anxiety and pain within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took nitrofurantoin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 12Apr2021 at 09:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 06:30, the patient experienced slight fever (100.3). Her regular temperature was usually around 96.5. She also experienced wheezing, excessive fatigue, weakness, dizziness, ringing in the ears, headache and nausea. On the same day, the patient underwent body temperature test and the result was 100.3 (unit unspecified). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with ipratropium bromide (ATROVENT NEBULIZER), salbutamol (VENTOLIN), paracetamol (TYLENOL) and ondansetron (ZOFRAN) . Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's slight fever (100.3), wheezing, excessive fatigue, weakness, dizziness, ringing in the ears, headache and nausea was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812353
Sex: F
Age:
State: TX

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Painful knot in left arm that moved locations: from site of injection to inside/ under arm then back to middle of arm and now on the outside of arm.; Painful knot in left arm that moved locations: from site of injection to inside/ under arm then back to middle of arm and now on the outside of arm.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm right on 19Mar2021 at 12:00(at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously took PERCOCET on an unknown date for unknown indication and experienced drug allergy. On 20Mar2021, the patient experienced painful knot in left arm that moved locations from site of injection to inside/ under arm then back to middle of arm and now on the outside of arm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events painful knot in left arm that moved locations, from site of injection to inside/ under arm then back to middle of arm and now on the outside of arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812354
Sex: M
Age:
State: WA

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: SARS-CoV-2 test; Test Result: Negative; Comments: I was tested but negative.

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Increased arthritic pain in fingers but not in the finger joints; This is a spontaneous report received from a contactable consumer (patient) reported for himself. A 66-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6208, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 11Mar2021 at 15:00 pm age at vaccination was 66 years as dose 2, single for COVID-19 immunization. The patient's medical history included type II diabetes from an unknown date. Concomitant medication the patient received within 2 weeks of vaccination included VYVANSE taken for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6201, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 10Feb2021 at 14:30 pm age at vaccination was 66 years as dose 1, single for COVID-19 immunization. The patient previously took codeine and egg based flu shots and experienced known allergies to it. The facility where the most recent COVID-19 vaccine was administered was Hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 12Mar2021 at 13:00 pm, the patient experienced increased arthritic pain in fingers but not in the finger joints. The patient received treatment with Advil for the event. The patient underwent lab test which included SARS-CoV-2 test negative on an unspecified date. The device date was reported as 08May2021. The outcome of the event was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds: VYVANSE

Current Illness:

ID: 1812355
Sex: F
Age:
State:

Vax Date: 05/06/2021
Onset Date: 05/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result: normally my temperature only went like 97 point so Fahrenheit; Comments: normally my temperature only went like 97 point something; Test Date: 20210508; Test Name: Body temperature; Result Unstructured Data: Test Result: 99.9 Fahrenheit; Test Name: Rapid test; Test Result: Negative.

Allergies:

Symptom List: Nausea

Symptoms: Body aches; Fever/Had a body temperature of 99.9F; Just arm was a little sore; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number was not reported), via an unspecified route of administration on 06May2021 at the age of 63-year-old) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number was not reported), via an unspecified route of administration on 15Apr2021 as single dose for COVID-19 immunization and she had lost her voice and had hoarseness. The patient got second dose of the Pfizer vaccine on Thursday afternoon (06May2021). And she did find as far as side effects that day and the next day, just arm was a little sore. But now today (08May2021) she woke up feeling kind of body achy, she took her temperature, and it's 99.9F, for her that's high because normally her temperature only went like 97 point something. So she was wondering and read the fact sheet that given to her with the vaccine but she did not see for it said how long after one get the vaccine, get the side effects could possibly come up. So she was wondering if it's normal, but still, stated, she had a fever. She wanted to know how long usually side effects last. The patient underwent lab tests and procedures which included rapid test negative on an unspecified date. Outcome of the events was unknown. No follow-up attempts are needed, information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1812356
Sex: F
Age:
State: MA

Vax Date: 05/03/2021
Onset Date: 05/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Metallic taste in mouth right after the shot; This is a spontaneous report from a contactable healthcare professional, the patient. A 50-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 03May2021 at 16:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient received other vaccine within 4 weeks prior to COVID-19 vaccination which included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient previously received METOCLPRAMIDE and experienced drug allergy. On 03May2021 at 16:15 (reported as 04:15), the patient experienced metallic taste in mouth right after the shot. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event metallic taste in mouth right after the shot was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812357
Sex: F
Age:
State: MO

Vax Date: 05/03/2021
Onset Date: 05/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Sore arm; Severe headache; Body/joint aches; Body/joint aches; nausea; Dizziness; Chills; Sweating; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 03May2021 at 13:45 at the age of 43-years-old as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS), hashimoto's disease, allergy to gold, cobalt, nickel, disperse blue dye, and adhesives. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included unspecified birth control pill from unknown date and unknown if ongoing, also ATORVASTATIN and SYNTHYROID, both for unknown indication from unknown date and unknown if ongoing. The patient previously took THIMEROSAL and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 12Apr2021 at 13:45 at the age of 43-years-old as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03May2021 at 21:00, the patient experienced sore arm, severe headache, body and joint aches, nausea, dizziness, chills, sweating, and diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, severe headache, body and joint aches, nausea, dizziness, chills, sweating, and diarrhea was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; SYNTHYROID

Current Illness:

ID: 1812358
Sex: F
Age:
State: PA

Vax Date: 05/02/2021
Onset Date: 05/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Diarrhea; Vomiting; Headache; Body aches; Slept all day; Pain when breathing; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 02May2021 at 08:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, allergy to sulphate drugs and eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control medications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 11Apr2021 at 13:15 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. On 03May2021, at 05:00, the patient experienced diarrhea, vomiting, headache, body aches, slept all day and pain when breathing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, vomiting, headache, body aches, slept all day and pain when breathing was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812359
Sex: F
Age:
State: GA

Vax Date: 04/30/2021
Onset Date: 04/30/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Weird vivid dreams now for 5 nights; This is a spontaneous report from a contactable nurse, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 30Apr2021 at 10:30(at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included butalbital, caffeine, paracetamol (FIORICET) for an unknown indication from an unknown date and unknown if ongoing. The patient previously took ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 30Apr2021, the patient experienced weird vivid dreams now for 5 nights(as reported). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event weird vivid dreams was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FIORICET

Current Illness:

ID: 1812360
Sex: F
Age:
State:

Vax Date: 03/30/2021
Onset Date: 04/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Swollen supraclavicular lymph node on left side of neck, above collar bone; Also some mild pain, discomfort in groin area and underarms; Also some mild pain, discomfort in groin area and underarms; Also some mild pain, discomfort in groin area and underarms; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 30Mar2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, hashimoto's disease, anxiety and gluten intolerance. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. On 06Apr2021, the patient experienced swollen supraclavicular lymph node on left side of neck, above collar bone and also had some mild pain, discomfort in groin area and underarms. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen supraclavicular lymph node on left side of neck, above collar bone, some mild pain, discomfort in groin area and underarms was recovered on an unknown date in 2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 20Apr2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE; SERTRALINE

Current Illness:

ID: 1812361
Sex: F
Age:
State: OH

Vax Date: 04/15/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Ringing Ears; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 15Apr2021 at 18:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and no known allergies reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol succinate (METOPROLOL) started on an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 25Mar2021 at 18:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced ringing ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing ears was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METOPROLOL

Current Illness:

ID: 1812362
Sex: F
Age:
State: VA

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210416; Test Name: SARS CoV-2 test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: left arm still sore on a 3 inch diameter from where shot was given- now 3 and half weeks later; Under arm lymph swollen on left side; Under arm lymph swollen on left side, tender; Inappropriate schedule of vaccine administered to Dose 1: 30Mar2021; Dose 2: 10Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 10Apr2021 at 11:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included Epstein barr active, Hashimoto's disease and sulfonamide allergy(sulfa drugs). Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medications included low dose naltrexone (MANUFACTURER UNKNOWN) and glycerine monolaurate (MONOLAURIN); both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 30Mar2021 at 14:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021, the patient's left arm was still sore on a 3-inch diameter from where shot was given even after 3 and half weeks later and the patient's under arm lymph was swollen on left side and was tender. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. On 16Apr2021, the patient underwent Nasal swab, SARS CoV-2 test and the result was negative. The clinical outcome of the events left arm still sore, under arm lymph swollen on left side and tender were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NALTREXONE; MONOLAURIN [GLYCERINE MONOLAURATE]

Current Illness:

ID: 1812363
Sex: F
Age:
State: TX

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Body aches all over and a headache; Body aches all over and a headache; Even "my" fingers and toes were hurting; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 04May2021 at 13:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included one a day prenatal vitamins (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 13:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 01:15, about 12 hours after shot, the patient experienced body aches all over and a headache and even the patient's fingers and toes were hurting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches all over and a headache and even "my" fingers and toes were hurting was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812364
Sex: F
Age:
State: ME

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: migraine headaches; Ringing in the ears since after 1st dose and has not stopped and not getting migraine headaches; This is a spontaneous report from a contactable nurse, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an intramuscular route of administration in the arm left on 29Dec2020 as a single dose for COVID-19 immunisation. Medical history included contrast dye allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN XL) and pantoprazole sodium sesquihydrate (PROTONIX); all on an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Dec2020, the patient experienced ringing in the ears since after 1st dose and has not stopped and now started getting migraine headaches. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in the ears and migraine headaches was not recovered at the time of this report. The patient received second dose of BNT162b2 (COMIRNATY; Lot number: EL3246), via an unspecified route of administration in the arm left on an unknown date as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN XL; PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]

Current Illness:

ID: 1812365
Sex: F
Age:
State: IN

Vax Date:
Onset Date: 04/13/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Dizziness from time to time; Irregular menstural; Headaches; This is a spontaneous report from a contactable healthcare professional, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration on an unknown date (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021, the patient experienced dizziness from time to time, irregular menstrual and headaches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, irregular menstrual and headaches were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812366
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Swollen lymph nodes in armpit; Fatigue; Painful joints; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration on an unknown date in 2021 (at the age of 37-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced swollen lymph nodes in armpit, fatigue and painful joints. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes in armpit, fatigue and painful joints were resolving at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812367
Sex: F
Age:
State: IN

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Dizziness; Diarrhea; Painful joints; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 at 10:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included vasculitis, heart disease, stage three kidney disease and allergy to sulpha drugs. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 09:00 as a single dose for COVID-19 immunisation. On 05May2021 at 00:00, the patient experienced dizziness, diarrhea and painful joints. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, diarrhea and painful joints was not resolved at the time of the report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: METOPROLOL; GABAPENTIN; LISINOPRIL

Current Illness:

ID: 1812368
Sex: F
Age:
State: CA

Vax Date: 04/18/2021
Onset Date: 05/02/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Hives on face, ears, arms and legs; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 18Apr2021 at 13:15 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient did not have relevant medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications within two weeks prior to vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 at 12:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. On 02May2021, two weeks after the second dose of vaccination, the patient experienced hives on the face, ears and later spread to arms and legs. The event resulted in doctor or other healthcare professional office/clinic visits. Therapeutic measures were taken as a result of hives on the face, ears, arms and legs which included treatment with prednisone steroid (MANUFACTURER UNKNOWN) from an unknown date and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hives on face, ears, arms and legs was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812369
Sex: F
Age:
State: TX

Vax Date: 05/03/2021
Onset Date: 05/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Fever; Massive migraine; Entire right upper arm swollen; Entire right upper arm hot to touch for past 2 days; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03May2021 at 16:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 03May2021 (also reported as at 15:45), the patient experienced fever, massive migraine, entire right upper arm swollen and hot to touch for past 2 days. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, massive migraine, entire right upper arm swollen and hot to touch for past 2 days was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1812370
Sex: F
Age:
State: TX

Vax Date: 03/30/2021
Onset Date: 04/08/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Continuous headache and vertigo; Continuous headache and vertigo; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at the age of 40-years-old as a single dose for COVID-19 immunisation. Medical history included anxiety and attention deficit disorder (ADD). The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included ZOLOFT and BUSPIRONE, both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 07Mar2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021, the patient experienced continuous headache and vertigo. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events continuous headache and vertigo was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; BUSPIRONE

Current Illness:

ID: 1812371
Sex: F
Age:
State: OH

Vax Date: 04/27/2021
Onset Date: 04/28/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210428; Test Name: Body temperature; Result Unstructured Data: Test Result: 100; Comments: Fever of 100.

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: More tender injections site; Tiredness; Chills; Body aches; Fever of 100; Nausea; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 12:00 at the age of 56-years-old as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified antibiotic, taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 16:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 02:00, in regards to the second shot, 14 hours after the injection, the patient experienced more tender injection site, tiredness, chills, body aches, fever of 100 (unspecified units), nausea, and feeling unwell which had lasted for 12 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events more tender injection site, tiredness, chills, body aches, fever of 100, nausea, and feeling unwell was resolved on 28Apr2021. No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1812372
Sex: F
Age:
State: CO

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: migraine today 08may it had still not gone away and was getting worse; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 33-year-old non pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Lot Number: EN5313) via an unspecified route of administration, administered in arm left on 04May2021 12:45 pm (at the age of 33 years) as dose 2, single for COVID-19 immunisation. The medical history included as none relevant history. Concomitant medication were metformin hydrochloride (METFORMIN ER); spironolactone (SPIRONOLACTONE), all from an unspecified date to an unspecified date taken for an unspecified indication. Historical vaccine included first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection Lot Number: EL9267) via an unspecified route of administration, administered in arm left on 13Apr2021 12:45 pm as dose 1, single for COVID-19 immunisation. She had no known allergies. She was not diagnosed with COVID prior to vaccination. she was not tested for COVID post vaccination. She did not receive any other vaccine in four weeks. On 05May2021 03:30, the patient experienced migraine today 08may it had still not gone away and was getting worse. The resulted events lead to visit emergency room. Therapeutic measures were taken. The clinical outcome of events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: METFORMIN ER; SPIRONOLACTONE

Current Illness:

ID: 1812373
Sex: F
Age:
State: GA

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Severe headaches; dizziness; nonstop nose bleed; early start and much longer; much heavier menstrual cycle; This is a spontaneous report from a Contactable Consumer or other non-health care professional (Patient). A 48-years-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch No: Not reported/Lot Number: ER8734) via an unspecified route of administration, administered in Arm Right on 24Apr2021 12:30 PM (age at vaccination 48 years old) as dose 1, single for covid-19 immunization, at Pharmacy or Drug Store. Medical history included migraine. Concomitant medications included other medications within two weeks of vaccination was fluoxetine hydrochloride (PROZAC); bupropion (BUPROPION); sumatriptan succinate (IMITREX) all were taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. No other vaccine taken in four weeks of vaccination. It was unknown patient had covid-19 prior vaccination and not tested post vaccination. On 24Apr2021 at 22:45, patient experienced with severe headache, dizziness, non-stop nosebleed (Patient do not get nose bleeds) and early start and much longer/much heavier menstrual cycle. Information on whether patient experienced Covid-19 prior vaccination was unknown. No therapeutic measures were taken as a result of events. The outcome for the reported events were not recovered. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021555112 similar report from same reporter

Other Meds: PROZAC; BUPROPION; IMITREX

Current Illness:

ID: 1812374
Sex: F
Age:
State: MO

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Hives; This is a spontaneous report from a contactable physician. A 47-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6200) intramuscularly, administered in Arm Left on 19Feb2021 17:00 (at the age old 47-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included major depressive disorder from 1990 ongoing (Stable with medication (and dose irrelevant), ADHD (attention deficit hyperactivity disorder) from 1974 ongoing (Stable with medication), Seasonal Allergies, and possible eczema from 1977 ongoing (Cetirizine and Zyrtec) controls symptoms well). Family medical history asthma Father- Asthma, severe seasonal allergies (but respond well to medication), Brother- Moderate to severe seasonal allergies (respond well to medication), Nephew (Brother's son)- Moderate to severe seasonal allergies (respond well to medication). Concomitant medication(s) included PROZAC DURAPAC orally taken for depression from 1995 and ongoing; WELLBUTRIN orally taken for depression from 2013 and ongoing; ADDERALL orally taken for attention deficit hyperactivity disorder from 2019 and ongoing; CETIRIZINE orally taken for allergies from 2019 and ongoing; IBUPROFEN orally taken for headache from 1983 and ongoing as needed. The patient previously took first dose of covid-19 vaccine on 29Jan2021 11:00 for covid-19 immunisation. The patient experienced hives on 19Feb2021 18:00. No treatment received. The outcome of event was recovered. Follow-up attempts completed. No further information expected.

Other Meds: PROZAC DURAPAC; WELLBUTRIN; ADDERALL; CETIRIZINE; IBUPROFEN

Current Illness:

ID: 1812375
Sex: F
Age:
State:

Vax Date: 05/08/2021
Onset Date: 05/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: itchiness on arm and leg/my arms and legs are very itchy; Feeling warm a little bit; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date were not reported), via an unspecified route of administration on 08May2021, as dose 2, single for Covid 19 immunization. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: Solution for injection, Lot number and expiry date were not reported) via an unspecified route of administration on an unspecified date as dose 1, single for Covid-19 immunization. The patient received second dose of vaccine yesterday morning (08May2021). The patient was really itchy last night (on 08May2021) and so went to sleep and woke up really itchy, her arms and legs were very itchy. In May2021, the patient was feeling warm a little bit but not like anything super serious. Outcome of events were not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am